Cargando…

Natural (∆(9)-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB(1) receptor

Natural cannabinoids and their synthetic substitutes are the most widely used recreational drugs. Numerous clinical cases describe acute toxic symptoms and neurological consequences following inhalation of the mixture of synthetic cannabinoids known as “Spice.” Here we report that an intraperitoneal...

Descripción completa

Detalles Bibliográficos
Autores principales: Malyshevskaya, Olga, Aritake, Kosuke, Kaushik, Mahesh K., Uchiyama, Nahoko, Cherasse, Yoan, Kikura-Hanajiri, Ruri, Urade, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585372/
https://www.ncbi.nlm.nih.gov/pubmed/28874764
http://dx.doi.org/10.1038/s41598-017-10447-2
_version_ 1783261610634117120
author Malyshevskaya, Olga
Aritake, Kosuke
Kaushik, Mahesh K.
Uchiyama, Nahoko
Cherasse, Yoan
Kikura-Hanajiri, Ruri
Urade, Yoshihiro
author_facet Malyshevskaya, Olga
Aritake, Kosuke
Kaushik, Mahesh K.
Uchiyama, Nahoko
Cherasse, Yoan
Kikura-Hanajiri, Ruri
Urade, Yoshihiro
author_sort Malyshevskaya, Olga
collection PubMed
description Natural cannabinoids and their synthetic substitutes are the most widely used recreational drugs. Numerous clinical cases describe acute toxic symptoms and neurological consequences following inhalation of the mixture of synthetic cannabinoids known as “Spice.” Here we report that an intraperitoneal administration of the natural cannabinoid Δ(9)-tetrahydrocannabinol (10 mg/kg), one of the main constituent of marijuana, or the synthetic cannabinoid JWH-018 (2.5 mg/kg) triggered electrographic seizures in mice, recorded by electroencephalography and videography. Administration of JWH-018 (1.5, 2.5 and 5 mg/kg) increased seizure spikes dose-dependently. Pretreatment of mice with AM-251 (5 mg/kg), a cannabinoid receptor 1-selective antagonist, completely prevented cannabinoid-induced seizures. These data imply that abuse of cannabinoids can be dangerous and represents an emerging public health threat. Additionally, our data strongly suggest that AM-251 could be used as a crucial prophylactic therapy for cannabinoid-induced seizures or similar life-threatening conditions.
format Online
Article
Text
id pubmed-5585372
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55853722017-09-06 Natural (∆(9)-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB(1) receptor Malyshevskaya, Olga Aritake, Kosuke Kaushik, Mahesh K. Uchiyama, Nahoko Cherasse, Yoan Kikura-Hanajiri, Ruri Urade, Yoshihiro Sci Rep Article Natural cannabinoids and their synthetic substitutes are the most widely used recreational drugs. Numerous clinical cases describe acute toxic symptoms and neurological consequences following inhalation of the mixture of synthetic cannabinoids known as “Spice.” Here we report that an intraperitoneal administration of the natural cannabinoid Δ(9)-tetrahydrocannabinol (10 mg/kg), one of the main constituent of marijuana, or the synthetic cannabinoid JWH-018 (2.5 mg/kg) triggered electrographic seizures in mice, recorded by electroencephalography and videography. Administration of JWH-018 (1.5, 2.5 and 5 mg/kg) increased seizure spikes dose-dependently. Pretreatment of mice with AM-251 (5 mg/kg), a cannabinoid receptor 1-selective antagonist, completely prevented cannabinoid-induced seizures. These data imply that abuse of cannabinoids can be dangerous and represents an emerging public health threat. Additionally, our data strongly suggest that AM-251 could be used as a crucial prophylactic therapy for cannabinoid-induced seizures or similar life-threatening conditions. Nature Publishing Group UK 2017-09-05 /pmc/articles/PMC5585372/ /pubmed/28874764 http://dx.doi.org/10.1038/s41598-017-10447-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Malyshevskaya, Olga
Aritake, Kosuke
Kaushik, Mahesh K.
Uchiyama, Nahoko
Cherasse, Yoan
Kikura-Hanajiri, Ruri
Urade, Yoshihiro
Natural (∆(9)-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB(1) receptor
title Natural (∆(9)-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB(1) receptor
title_full Natural (∆(9)-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB(1) receptor
title_fullStr Natural (∆(9)-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB(1) receptor
title_full_unstemmed Natural (∆(9)-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB(1) receptor
title_short Natural (∆(9)-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB(1) receptor
title_sort natural (∆(9)-thc) and synthetic (jwh-018) cannabinoids induce seizures by acting through the cannabinoid cb(1) receptor
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585372/
https://www.ncbi.nlm.nih.gov/pubmed/28874764
http://dx.doi.org/10.1038/s41598-017-10447-2
work_keys_str_mv AT malyshevskayaolga natural9thcandsyntheticjwh018cannabinoidsinduceseizuresbyactingthroughthecannabinoidcb1receptor
AT aritakekosuke natural9thcandsyntheticjwh018cannabinoidsinduceseizuresbyactingthroughthecannabinoidcb1receptor
AT kaushikmaheshk natural9thcandsyntheticjwh018cannabinoidsinduceseizuresbyactingthroughthecannabinoidcb1receptor
AT uchiyamanahoko natural9thcandsyntheticjwh018cannabinoidsinduceseizuresbyactingthroughthecannabinoidcb1receptor
AT cherasseyoan natural9thcandsyntheticjwh018cannabinoidsinduceseizuresbyactingthroughthecannabinoidcb1receptor
AT kikurahanajiriruri natural9thcandsyntheticjwh018cannabinoidsinduceseizuresbyactingthroughthecannabinoidcb1receptor
AT uradeyoshihiro natural9thcandsyntheticjwh018cannabinoidsinduceseizuresbyactingthroughthecannabinoidcb1receptor